ReviewAnnals of translational medicine2019
Three-dimensional printing in structural heart disease and intervention.
Review in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 30 citations in OpenAlex.
- Simultaneous TAVR and TMVR-in-MAC guided by 3D modelling and prosthesis modification: a case report.European heart journal. Case reports · 2026Article
- A 3D Printing-Based Transcatheter Pulmonary Valve Replacement Simulator: Development and Validation.Bioengineering (Basel, Switzerland) · 2025Article
- The Application of Precision Medicine in Structural Heart Diseases: A Step towards the Future.Journal of personalized medicine · 2024Review
- Feasibility of 3-dimensional printed models in simulated training and teaching of transcatheter aortic valve replacement.Open medicine (Warsaw, Poland) · 2024Article
- Three-dimensional printed models as an effective tool for the management of complex congenital heart disease.Frontiers in bioengineering and biotechnology · 2024Article
- Review
- Comparison of blood pool and myocardial 3D printing in the diagnosis of types of congenital heart disease.Scientific reports · 2022Article
- Computed tomography angiography/magnetic resonance imaging-based preprocedural planning and guidance in the interventional treatment of structural heart disease.Frontiers in cardiovascular medicine · 2022Article
- Three-dimensional printing for heart diseases: clinical application review.Bio-design and manufacturing · 2021Review
- Three-dimensional reconstruction/personalized three-dimensional printed model for thoracoscopic anatomical partial-lobectomy in stage I lung cancer: a retrospective study.Translational lung cancer research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Three-dimensional (3D) printing refers to the process by which physical objects are built by depositing materials in layers based on a specific digital design. It was initially used in manufacture industry. Inspired by the technology, clinicians have recently attempted to integrate 3D printing into medical applications. One of the medical specialties that has recently made such attempt is cardiology, especially in the field of structural heart disease (SHD). SHD refers to a group of non-coronary cardiovascular disorders and related interventions. Obvious examples are aortic stenosis, mitral regurgitation, atrial septal defect, and known or potential left atrial appendage (LAA) clots. In the last decade, cardiologists have witnessed a dramatic increase in the types and complexity of catheter-based interventions for SHD. Current imaging modalities have important limitations in accurate delineation of cardiac anatomies necessary for SHD interventions. Application of 3D printing in SHD interventional planning enables tangible appreciation of cardiac anatomy and allows
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.